Abstract
Purpose
The purpose of this study was to ascertain the prevalence and primary causes of visual impairment in a representative Canadian population.
Methods
We reviewed a representative sample of patients who attended ophthalmologists' offices in a medium-sized Canadian city between 1996 and 2001 in order to estimate the prevalence of visual impairment. Demographic data, visual diagnoses, best-corrected visual acuities (BCVA), and visual field information were recorded. Visual status was categorized based on accepted World Health Organization (WHO) and North American criteria. Population data were obtained from the Canadian census.
Results
The prevalence of low vision and blindness in our population was 35.6 and 3.8 per 10 000 individuals, according to the WHO classification, and 71.2 and 23.6 per 10 000 individuals, using the North American definition. Among individuals with some vision loss (vision worse than 20/40), cataract and visual pathway disease were the most common causes, together accounting for 40% of visual impairment. Age-related macular degeneration and other retinal diseases were the next most common causes of vision loss. Diabetic retinopathy and glaucoma were less frequently encountered as causes of visual impairment.
Conclusion
The overall prevalence of low vision and blindness in Canada are in keeping with data from large population-based studies from other developed nations. Cataract, visual pathway disease, and macular degeneration are the leading causes of visual impairment. These results are important for enhancing our understanding of the scope of vision health in Canada and may direct future health planning and cost-utilization research.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Hameed TK, Hodge WG, Buhrmann R . An inventory of information on blindness and visual impairment in Canada. Can J Ophthalmol 2001; 36: 175–185.
Maberley D . Discussion: an inventory of information on blindness and visual impairment in Canada. Can J Ophthalmol 2001; 36: 185–186.
Statistics Canada, Participation and Activity Limitation Survey 2001. www.hrdc-drhc.gc.ca/sp-ps/arb-dgra/publications/research/2001docs/PALS.
The Canadian National Institute for the Blind 2001 Client Data.
Tielsch JM, Sommer A, Witt K, Katz J, Royall RM . Blindness and visual impairment in an American urban population. The Baltimore Eye Survey. Arch Ophthalmol 1990; 108: 286–290.
Klein R, Klein BEK, Linton KLP, De Mets DL . The Beaver Dam Eye Study: visual acuity. Ophthalmology 1991; 98: 1310–1315.
Attebo K, Mitchell P, Smith W . Visual acuity and causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology 1996; 103: 357–364.
Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT . Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998; 116: 653–658.
Buch H, Vinding T, la Cour M, Appleyard M, Jensen GB, Nielsen NV . Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults. Ophthalmology 2004; 111: 53–61.
Buch H, Troels V, Nielsen NV . Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: The Copenhagen City Eye Study. Ophthalmology 2001; 108: 2347–2357.
Acknowledgements
Financial support: CNIB EA Baker Grant. Meeting presentation: UBC Department of Ophthalmology Annual Research Day May 2004.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maberley, D., Hollands, H., Chuo, J. et al. The prevalence of low vision and blindness in Canada. Eye 20, 341–346 (2006). https://doi.org/10.1038/sj.eye.6701879
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6701879
Keywords
This article is cited by
-
Treat-and-extend dosing of intravitreal anti-VEGF agents in neovascular age-related macular degeneration: a meta-analysis
Eye (2023)
-
Visual impairment and its predictors among people living with type 2 diabetes mellitus at Dessie town hospitals, Northeast Ethiopia: institution-based cross-sectional study
BMC Ophthalmology (2022)
-
Differences in macular vessel density in the superficial plexus across cognitive impairment: the NORFACE cohort
Scientific Reports (2022)
-
Characteristics, evolution, and outcome of patients with non-infectious uveitis referred for rheumatologic assessment and management: an Egyptian multicenter retrospective study
Clinical Rheumatology (2021)
-
Evaluation of the effect of unilateral late blindness on the retina, optic nerve and choroid parameters in the sighted eye
International Ophthalmology (2021)
